Form D · Private Equity Fund

Cormorant Private Healthcare Fund II, LP

Boston, MA · CIK 0001747677

Offering snapshot reported Aug 17, 2018 · SEC filing

Reported sold: $106M
Investors reported: 39
Minimum accepted: $0
First sale: Aug 2, 2018

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Aug 17, 2018	Initial	$105,550,000	No comparison	39	SEC filing

Offering details

Securities: Pooled investment fund, Other
Exemptions: 06b, 3C.7
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-319526

The aggregate total offering amount of the Issuer and its affiliated fund, Cormorant Private Healthcare Offshore Fund II, LP will be $350,000,000. The amounts reflected in this Form D are only for the Issuer.

Limited Partnership Interests. The General Partner may accept lesser amounts of the minimum investment of $5,000,000 at its discretion.

Source: Form D, filed Aug 17, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

CORMORANT PRIVATE HEALTHCARE FUND II, LP

Investment adviser: CORMORANT ASSET MANAGEMENT, LP

Gross asset value: $125M
Beneficial owners: 82
ADV minimum commitment: $5M

Reported in Form ADV on May 27, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator STONE COAST FUND SERVICES PORTLAND, Maine, United States Investor statements: Yes (provided to all investors) Related to adviser: No

Auditor DELOITTE & TOUCHE LLP BOSTON, Massachusetts, United States

Custodian MORGAN STANLEY & CO. LLC NEW YORK, New York, United States Related to adviser: No

Prime broker MORGAN STANLEY & CO. LLC NEW YORK, New York, United States

Provider details

Annual audit: Yes
Prime brokers: Yes
Custodians: Yes
Administrator other than the adviser: Yes
External marketing: No

DELOITTE & TOUCHE LLP
PCAOB 34

MORGAN STANLEY & CO. LLC
SEC 8-15869

MORGAN STANLEY & CO. LLC
CRD 8209 · SEC 8-15869

Filing source

Form ADV 2108497 · May 27, 2026 · Schedule D 7.B.(1), fund 805-9740174730

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Bihua Chen	Executive, Promoter
N/A Cormorant Asset Management, Lp	Promoter
N/A Cormorant Private Healthcare Gp Ii, Llc	Executive, Promoter
Jay Scollins	Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

200 Clarendon Street 52 Nd Floor
Boston, MA, 02116